Chronic lymphocytic leukaemia vaccine (Vasogen)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameChronic lymphocytic leukaemia vaccine (Vasogen)
Drug Alias NameCLL vaccine - VasogenImmune modulation therapy-chronic lymphocytic leukaemia - Vasogen
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVasogen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVasogen
Active IndicationsN/A
Inactive IndicationsLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A